A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
Clinical trial NCT05113953 · COMPLETED
Trial details
- NCT number
- NCT05113953
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-22
- Primary completion
- 2022-08-19
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.